US5534546A - Indene derivatives and antimicrobial agents containing same - Google Patents

Indene derivatives and antimicrobial agents containing same Download PDF

Info

Publication number
US5534546A
US5534546A US08/372,729 US37272995A US5534546A US 5534546 A US5534546 A US 5534546A US 37272995 A US37272995 A US 37272995A US 5534546 A US5534546 A US 5534546A
Authority
US
United States
Prior art keywords
antimicrobial
formula
indene
methyl alcohol
indene derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US08/372,729
Inventor
Yukio Ishiguro
Youji Sonoda
Kenji Okamoto
Takamitsu Okamoto
Hideki Sakamoto
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kagome Co Ltd
Original Assignee
Kagome Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP9866993A external-priority patent/JP2754312B2/en
Priority claimed from JP10998493A external-priority patent/JP2754313B2/en
Application filed by Kagome Co Ltd filed Critical Kagome Co Ltd
Priority to US08/372,729 priority Critical patent/US5534546A/en
Assigned to SONODA, YOUJI, KAGOME KABUSHIKI KAISHA reassignment SONODA, YOUJI CORRECTIVE ASSIGNMENT TO ADD AN ASSIGNEE TO A DOCUMENT PREVIOUSLY RECORDED ON REEL 6938 FRAME 0636. . Assignors: ISHIGURO, YUKIO, OKAMOTO, KENJI, OKAMOTO, TAKAMITSU, SAKAMOTO, HIDEKI, SONODA, YOUJI
Application granted granted Critical
Publication of US5534546A publication Critical patent/US5534546A/en
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/587Unsaturated compounds containing a keto groups being part of a ring
    • C07C49/753Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups
    • C07C49/755Unsaturated compounds containing a keto groups being part of a ring containing ether groups, groups, groups, or groups a keto group being part of a condensed ring system with two or three rings, at least one ring being a six-membered aromatic ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78Separation; Purification; Stabilisation; Use of additives
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C49/00Ketones; Ketenes; Dimeric ketenes; Ketonic chelates
    • C07C49/527Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings
    • C07C49/577Unsaturated compounds containing keto groups bound to rings other than six-membered aromatic rings containing ether groups, groups, groups, or groups

Definitions

  • This partition 1.8 g was dissolved in methyl alcohol for a first high performance liquid chromatographic test by using an ODS column (CAPCELL PAK C 18 , trade name of Shiseido Co., Ltd.: 20 mm ⁇ 250 mm).
  • the flow rate was 3.0 ml/minute.
  • Ultraviolet absorbance at 254 nm was detected and six partitions showing principal peaks were obtained.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

Abstract

New indene derivative, obtainable from etiolated seedlings of Adlay and shown by Formulas (1) and (2) given below, have antimicrobial effects and can serve as effective components of antimicrobial agents: ##STR1##

Description

This is a continuation of application Ser. No. 08/218,537, filed Mar. 28, 1994, now abandoned.
BACKGROUND OF THE INVENTION
This invention relates to indene derivatives and antimicrobial agents containing such indene derivatives as effective components.
It has been known that etiolated seedlings of Adlay have antimicrobial activities, whether in a dried form, as a squeezed juice or as an extract. As examples of compound having this kind of antimicrobial activity, Japanese Patent Publications Tokkai 2-270825 and 3-240473 have suggested monoglycerides of stearic acid and palmitic acid, as well as their derivatives.
SUMMARY OF THE INVENTION
It is an object of the present invention to provide new indene derivatives which are isolated from etiolated seedlings of Adlay and show superior antimicrobial activities.
The present inventors have discovered, as a result of their diligent investigations into the antimicrobial activities exhibited by etiolated seedlings of Adlay in a dried form, as a squeezed juice or an extract, that new indene derivatives can be isolated if etiolated seedlings of Adlay are processed in a certain specified manner.
DETAILED DESCRIPTION OF THE INVENTION
This invention relates to new indene derivatives shown by Formulas (1) and (2) shown below, as well as antimicrobial agents containing such indene derivatives as their effective component: ##STR2##
A process for obtaining the indene derivatives as shown by Formulas (1) and (2) is described next. First, etiolated seedlings of Adlay are obtained by causing Adlay seeds to germinate in a dark environment, as will be described in detail below by way of examples. Examples of Adlay which may be used according to the present invention include local varieties such as Tokuda, Nakazato, Okayama and Kuroishi. The invention is not limited by the use of any particular kind. As for the process itself, use may be made of any usual method of obtaining etiolated seedlings by germinating in the dark. For example, Adlay seeds may be germinated in the dark for 4-8 days at 25° C. Nearly the entirety of etiolated seedlings of Adlay thus obtained can be used for the purpose of this invention.
Next, the etiolated seedlings of Adlay thus obtained, or what may be obtained therefrom by grinding, freeze-drying or pulverizing, are subjected to an extraction process by using methyl alcohol or ethyl alcohol such that an extract is obtained. Next, the extract thus obtained is subjected to a liquid-liquid partition extraction process by using a combination of methyl alcohol or ethyl alcohol and chloroform. After a chloroform layer is separated, another liquid-liquid partition process is carried out by using a combination of this chloroform and acetone. A simple lipid, which is easily dissolved in acetone, is obtained therefrom after an acetone layer is separated.
Lastly, this simple lipid is subjected to a chromatographical separation process by chromatography using mobile phases with different polarities. Separation processes are repeated and the two kinds of target compounds are separated by their different retention times. It is preferable to carry out the chromatographical separation process by a combination of gel permeation chromatography and high performance liquid chromatography by using mobile phases with different polarities.
The physical and chemical properties of one of the two compounds thus separated are as follows:
(1) Molecular weight: 190 (C11 H10 O3)
(2) Infrared spectrum: 1585, 1703, 3050cm-1
(3) Chemical shift by 1 H-NMR: 3.99 (3H, s), 4.09 (3H, s), 5.98 (1H, s), 7.19 (1H, dd, J=8.79, 2.56), 7.56 (1H, d, J=2.56), 8.00 (1H, d, J=8.79)
(4) Chemical shift by 13 C-NMR: 57.7, 58.7, 105.6, 112.3, 118.1, 126.1, 133.2, 136.6, 167.2, 169.3, 181.5 From these physical and chemical properties, the first of the separated compounds has been determined to be the indene derivative shown by Formula (1) which is 3,5-dimethoxy-1H-inden-1-one.
The physical and chemical properties of the other of these two separated compounds are as follows:
(1) Molecular weight: 234 (C13 H14 O4)
(2) Infrared spectrum: 1569, 1712, 3401cm-1
(3) Chemical shift by 1 H-NMR: 2.01 (3H, s), 3.84 (3H, s), 4.00 (3H, s), 5.68 (1H, s), 7.08 (1H, dd, J=8.55, 2.67), 7.37 (1H, d, J=2.67), 7.57 (1H, d, J=8.55)
(4) Chemical shift by 13 C-NMR: 31.6, 55.9, 57.1, 76.0, 99.1, 109.5, 117.2, 128.7, 129.0, 137.0, 160.3, 168.3, 205.0
From these physical and chemical properties, the second of the separated compounds has been determined to be the indene derivative shown by Formula (2) which is 1-acetyl-1-hydroxy-3,5-dimethoxy-1H-inden.
As will be described more in detail below, the indene derivative shown by Formula (1) demonstrates superior antimicrobial activities against bacteria, yeasts and fungi, and the indene derivative shown by Formula (2) demonstrates superior antimicrobial activities against bacteria. In other words, both these indene derivatives are useful to foods and cosmetic items as natural antimicrobial agents.
EXAMPLES Test No. 1: Separation of indene derivative shown by Formula (1)
Etiolated seedlings of Adlay were obtained by geminating Adlay seeds of Tokuda variety for four days at 25° C. After these seedlings were ground, they were freeze-dried at shelf temperature of 20° C. to obtain a freeze-dried object. After methyl alcohol 6 liters was added to 150 g of this freeze-dried object, it was homogenized and left quietly for 48 hours at room temperatures. It was then filtered to obtain an extract solution. Methyl alcohol 6 liters was added to the residue to similarly obtain another extract solution and this extract solution was added to the earlier obtained extract solution. This mixture was heated at 40°-45° C. under a reduced pressure condition to evaporate the methyl alcohol, obtaining 30 g of an extract.
Methyl alcohol 100 ml and chloroform 200 ml were added to 30 g of this extracted object. The mixture was stirred, 60 ml of 0.8% aqueous solution of potassium chloride was added thereto and the mixture was left quietly. After a chloroform layer was removed and the solution was heated at 40°-45° C. under a reduced pressure condition to condense it to 1 ml, 10 ml of acetone and 0.2 ml of 10% methyl alcohol solution of magnesium chloride were added, mixed and stirred. After it was cooled with ice for one hour, a supernatant acetone solution was collected by centrifugal separation. Acetone 10 ml and 10% methyl alcohol solution of magnesium chloride 0.2 ml were added to the residue to similarly obtain another acetone solution, which was added to the earlier obtained acetone solution. The mixed acetone solution was heated at 40°-45° C. under a reduced pressure condition to evaporate acetone and to obtain 7.1 g of a simple lipid which dissolves in acetone easily.
The simple lipid 7.1 g thus obtained was dissolved in chloroform for gel permeation chromatography by using two polystyrene polymer columns (JAIGEL 1H, trade name of Nippon Bunseki Kogyo Co., Ltd.: 8.0 mmφ×500 mm). Chloroform was used in the mobile phase with flow rate of 3.5 ml/minute. Refractive index (RI) was detected, and four partitions showing principal peaks were obtained. Antimicrobial effects of these partitions were tested by the paper disc method against Bacillus subtilis, Saccharomyces cerevisiae and Aspergillus niger, and 1.8 g of a partition showing the strongest antimicrobial activity with retention time (Rt)=55-64 minutes was obtained.
This partition 1.8 g was dissolved in methyl alcohol for a first high performance liquid chromatographic test by using an ODS column (CAPCELL PAK C18, trade name of Shiseido Co., Ltd.: 20 mmφ×250 mm). The mobile phase was methyl alcohol/water=20/80 (weight ratio) to start with and it was changed by a linear gradient method to 100/0 after 30 minutes. The flow rate was 3.0 ml/minute. Ultraviolet absorbance (at 254 nm) was detected and six partitions showing principal peaks were obtained. By a similar antimicrobial test as described above, a partition of 146.4 mg showing the strongest antimicrobial activity with Rt=34-38 minutes was obtained. This partition of 146.4 mg thus obtained was dissolved in methyl alcohol for a second high performance liquid chromatographic test by using a CAPCELL PAK C18 column. The mobile phase for this test was methyl alcohol/water=50/50 (weight ratio) with flow rate of 3.0 ml/minute. Ultraviolet absorbance (at 254 nm) was detected and eight partitions showing principal peaks were obtained. By a similar antimicrobial test as described above, 12.8 g of a compound showing the strongest antimicrobial activity against all test bacteria with Rt=45 minutes was obtained.
The physical and chemical properties of the compound thus obtained are as presented above, and it was 3,5-dimethoxy-1H-inden-1-one shown by Formula (1).
Test No. 2: Separation of indene derivative shown by Formula (2)
An extract was obtained from 150 g of freeze-dried etiolated Adlay as in Test No. 1 by using methyl alcohol, and this extract was subjected to a liquid-liquid partition extraction process with a combination of methyl alcohol and chloroform and then to another liquid-liquid partition extraction process with a combination of chloroform and acetone to obtain a simple lipid which is easily dissolved in acetone. This simple lipid was used as in Test No. 1 for gel permeation chromatography and further for first high performance liquid chromatography to obtain a partition with Rt=34-38 minutes, having the strongest antimicrobial activity.
This partition was dissolved in methyl alcohol for second high performance liquid chromatography by using a CAPCELL PAK C18 column. The mobile phase in this case was methyl alcohol/water=50/50 (weight ratio) with flow rate of 3.0 ml/minute. Ultraviolet absorbance (at 254 nm) was detected and eight partitions showing principal peaks were obtained. By a similar antimicrobial test as described above, a partition with Rt=30 minutes and showing antimicrobial effects only against Bacillus subtilis was selected and used for a third high performance liquid chromatography process by again using a CAPCELL PAK C18 column. The mobile phase this time was methyl alcohol/water=25/75 (weight ratio) with flow rate of 3.0 ml/minute. Ultraviolet absorbance (at 254 nm) was detected and 1.5 mg of a compound with Rt=23 minutes was isolated.
The physical and chemical properties of the compound thus isolated are as presented above, and it was 1-acetyl-1-hydroxy-3,5-dimethoxy-1H-inden shown by Formula (2).
Test No. 3: Antimicrobial activities of isolated indene derivatives
Antimicrobial activities of the isolated indene derivatives shown by Formula (1) were tested against Bacillus subtilis, Saccharomyces cerevisiae and Aspergillus niger. Antimicrobial activities of the isolated indene derivatives shown by Formula (2) were tested against Bacillus subtilis. Both tests were carried out by a paper disk method. Use, as medium, was made of trypso-soya agar (product by Nissui Pharmaceutical Co., Ltd., containing peptone 1.5% soybean peptone 0.5% NaCl 0.5%, and agar 1.5%) for Bacillus subtilis and potato dextrose agar (product by Nissui Pharmaceutical Co., Ltd., extract of potato 0.4%, glucose 2.0%, agar 1.5%) for Saccharomyces cerevisiae and Aspergillus niger. These agar materials (15 ml) were each poured into a Petri dish to prepare a planar medium.
Bacteria to be tested were inoculated on a similarly prepared 15 ml agar medium and the latter was then place on top of the aforementioned planar medium and solidified. Paper discs (product by Toyo Roshi Kaisha, Ltd. with diameter=8 mm; thin) were placed on such a superposed plane medium, and 20 μl each of the isolated indene derivative shown by Formula (1) and (2) was dropped on the paper discs (200 μg/paper disc). The diameters of the halos were measured after 24 hours of culturing in the case of Bacillus subtilis and 48 hours in the case of Saccharomyces cerevisiae and Aspergillus niger. Averages were taken from values obtained from five paper discs and antimicrobial activities were obtained according to Formula (3) shown below:
Antimicrobial activity (mm)=(Diameter (mm) of halo)-(Diameter (mm) of paper disc)
The antimicrobial activity of the indene derivative shown by Formula (1) was 20.0 mm against Bacillus subtilis, 11.5 mm against Saccharomyces cerevisiae and 11.5 mm against Aspergillus niger, indicating that the indene derivative shown by Formula (2) has superior antimicrobial activities against bacteria, yeasts and fungi. The antimicrobial activity of the indene derivative shown by Formula (2) was 24.0 mm against Bacillus subtilis, indicating that the indene derivative shown by Formula (2) has superior antimicrobial activities against bacteria.
In summary, it has been shown that the indene derivatives according to the present invention are useful as natural antimicrobial agent.

Claims (4)

What is claimed is:
1. An indene derivative shown by Formula (1) given below: ##STR3##
2. An indene derivative shown by Formula (2) given below: ##STR4##
3. An antimicrobial agent having the indene derivative of claim 1 as effective component.
4. An antimicrobial agent having the indene derivative of claim 2 as effective component.
US08/372,729 1993-03-31 1995-01-17 Indene derivatives and antimicrobial agents containing same Expired - Lifetime US5534546A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US08/372,729 US5534546A (en) 1993-03-31 1995-01-17 Indene derivatives and antimicrobial agents containing same

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
JP5-098669 1993-03-31
JP9866993A JP2754312B2 (en) 1993-03-31 1993-03-31 Indene derivative and antibacterial agent containing the same as an active ingredient
JP5-109984 1993-04-12
JP10998493A JP2754313B2 (en) 1993-04-12 1993-04-12 Indene derivative and antibacterial agent containing the same as an active ingredient
US21853794A 1994-03-28 1994-03-28
US08/372,729 US5534546A (en) 1993-03-31 1995-01-17 Indene derivatives and antimicrobial agents containing same

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
US21853794A Continuation 1993-03-31 1994-03-28

Publications (1)

Publication Number Publication Date
US5534546A true US5534546A (en) 1996-07-09

Family

ID=26439796

Family Applications (1)

Application Number Title Priority Date Filing Date
US08/372,729 Expired - Lifetime US5534546A (en) 1993-03-31 1995-01-17 Indene derivatives and antimicrobial agents containing same

Country Status (3)

Country Link
US (1) US5534546A (en)
EP (1) EP0618182B1 (en)
DE (1) DE69401151D1 (en)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
US20070218041A1 (en) * 2001-11-09 2007-09-20 Michelle Lu Topical composition having undifferentiated plant seed cells and method for using same
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
EP2147679A2 (en) 2001-07-25 2010-01-27 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
WO2010095940A2 (en) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Glutathione-based drug delivery system
WO2012044761A1 (en) 2010-09-29 2012-04-05 University Of North Carolina At Wilmington Ladder-frame polyether conjugates
EP4218718A2 (en) 2009-05-06 2023-08-02 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069326A (en) * 1974-02-07 1978-01-17 Societe Anonyme Dite: Societe Hexachimie Morpholino containing indane acetic acid esters
US4333949A (en) * 1978-11-06 1982-06-08 Ciba-Geigy Corporation 1H-Inden-1-one derivatives, their use in microbicidal compositions, and for combating microorganisms
US5329050A (en) * 1992-04-28 1994-07-12 Hoechst Aktiengesellschaft Process for the preparation of substituted indanones, and their use

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7412828A (en) * 1974-07-30 1976-02-03 Merck & Co Inc METHOD FOR PREPARING SUBSTITUTED INDANYLOXYACETIC ACID COMPOUNDS; PROCESS FOR THE PREPARATION OF PHARMACEUTICAL PREPARATIONS AND THE OBJECTS OBTAINED BY THEIR APPLICATION.

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4069326A (en) * 1974-02-07 1978-01-17 Societe Anonyme Dite: Societe Hexachimie Morpholino containing indane acetic acid esters
US4333949A (en) * 1978-11-06 1982-06-08 Ciba-Geigy Corporation 1H-Inden-1-one derivatives, their use in microbicidal compositions, and for combating microorganisms
US5329050A (en) * 1992-04-28 1994-07-12 Hoechst Aktiengesellschaft Process for the preparation of substituted indanones, and their use

Cited By (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2147679A2 (en) 2001-07-25 2010-01-27 Raptor Pharmaceutical Inc. Compositions and methods for modulating blood-brain barrier transport
US20070218041A1 (en) * 2001-11-09 2007-09-20 Michelle Lu Topical composition having undifferentiated plant seed cells and method for using same
WO2006116718A2 (en) 2005-04-28 2006-11-02 Proteus Biomedical, Inc. Pharma-informatics system
EP2392258A1 (en) 2005-04-28 2011-12-07 Proteus Biomedical, Inc. Pharma-informatics system
EP3827747A1 (en) 2005-04-28 2021-06-02 Otsuka Pharmaceutical Co., Ltd. Pharma-informatics system
WO2008036682A2 (en) 2006-09-18 2008-03-27 Raptor Pharmaceutical Inc. Treatment of liver disorders by administration of receptor-associated protein (rap)-conjugates
WO2010095940A2 (en) 2009-02-20 2010-08-26 To-Bbb Holding B.V. Glutathione-based drug delivery system
EP4218718A2 (en) 2009-05-06 2023-08-02 Laboratory Skin Care, Inc. Dermal delivery compositions comprising active agent-calcium phosphate particle complexes and methods of using the same
WO2012044761A1 (en) 2010-09-29 2012-04-05 University Of North Carolina At Wilmington Ladder-frame polyether conjugates

Also Published As

Publication number Publication date
EP0618182B1 (en) 1996-12-18
DE69401151D1 (en) 1997-01-30
EP0618182A1 (en) 1994-10-05

Similar Documents

Publication Publication Date Title
Marotti et al. Effects of variety and ontogenic stage on the essential oil composition and biological activity of fennel (Foeniculum vulgare Mill.)
Ryan et al. Biotransformations of phenolic compounds in Olea europaea L.
Duraipandiyan et al. Antimicrobial, antioxidant, and cytotoxic properties of vasicine acetate synthesized from vasicine isolated from Adhatoda vasica L.
Jisaka et al. Antitumoral and antimicrobial activities of bitter sesquiterpene lactones of Vernonia amygdalina, a possible medicinal plant used by wild chimpanzees
Kato-Noguchi Isolation and identification of an allelopathic substance in Pisum sativum
Phay et al. An antifungal compound from roots of Welsh onion
Vargas-Arispuro et al. Antifungal lignans from the creosotebush (Larrea tridentata)
US5849956A (en) Antifungal terpene compounds and process for producing the same
US5534546A (en) Indene derivatives and antimicrobial agents containing same
Okezie et al. Antioxidant activities of extracts of endophytic fungi isolated from healthy leaves of Carica papaya
Ferdosi et al. Potential antimicrobial compounds in flower extract of Plumeria alba
Elhagali et al. Investigation of bioactive constituents and biological activities of different fractions from Herniaria hemistemon J. Gay
Khan et al. Structure and biological activity of xanthyletin, a new phytoalexin of citrus
Tassou Microbiology of olives with emphasis on the antimicrobial activity of phenolic compounds
KR100363112B1 (en) Novel Material Separated from Ecklonia cava, The Method for Extracting and Purifying the Same, And The Use Thereof for Antioxidants
Carrillo‐López et al. Betalains: chemistry and biological functions
EP0504186A1 (en) Thiarubrine antifungal and antibiotic agents
Cheah et al. Antimicrobial activity of Calophyllum inophyllum crude extracts obtained by pressurized liquid extraction
KR100447775B1 (en) Extracts derived from plants containing physiological activity
JP2754313B2 (en) Indene derivative and antibacterial agent containing the same as an active ingredient
KR20010098018A (en) Novel Material Separated from Ecklonia cava, The Method for Extracting and Purifying the Same, And The Use Thereof for Antioxidants
JP2566771B2 (en) 2- (2,4-dihydroxyphenyl) -4-methoxy-5- (3-methyl-2-butenyl) -6-hydroxycoumarone and preservative
Teo Antibacterials From Plants of the Tropical Rain Forests of Borneo
Iqbal et al. Isolation, characterization and antibacterial studies of three new chemical constituents isolated from Viburnum grandiflorum
Al-Bayati Antimicrobial activity of carnosic acid isolated from Rosmarinus officinalis L. leaves

Legal Events

Date Code Title Description
AS Assignment

Owner name: KAGOME KABUSHIKI KAISHA, JAPAN

Free format text: CORRECTIVE ASSIGNMENT TO ADD AN ASSIGNEE TO A DOCUMENT PREVIOUSLY RECORDED ON REEL 6938 FRAME 0636;ASSIGNORS:ISHIGURO, YUKIO;SONODA, YOUJI;OKAMOTO, KENJI;AND OTHERS;REEL/FRAME:007771/0001

Effective date: 19940310

Owner name: SONODA, YOUJI, JAPAN

Free format text: CORRECTIVE ASSIGNMENT TO ADD AN ASSIGNEE TO A DOCUMENT PREVIOUSLY RECORDED ON REEL 6938 FRAME 0636;ASSIGNORS:ISHIGURO, YUKIO;SONODA, YOUJI;OKAMOTO, KENJI;AND OTHERS;REEL/FRAME:007771/0001

Effective date: 19940310

STCF Information on status: patent grant

Free format text: PATENTED CASE

FEPP Fee payment procedure

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 4

FEPP Fee payment procedure

Free format text: PAYER NUMBER DE-ASSIGNED (ORIGINAL EVENT CODE: RMPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

Free format text: PAYOR NUMBER ASSIGNED (ORIGINAL EVENT CODE: ASPN); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY

FPAY Fee payment

Year of fee payment: 8

FPAY Fee payment

Year of fee payment: 12